Evolus, Inc.
Health
Performance
8.5
Risk
Sell
Buy
Curious about the Scores? Learn more.

Evolus, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

22.01.2026
Red alert. Risk levels out of control.
09.01.2026
Momentum tanked. Clearly underperforming.
07.01.2026
Rock bottom. The fall’s complete, stability nowhere to be found.

Evolus, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Evolus, Inc. do? Business model and key facts

Get the full picture of Evolus, Inc.: what it builds, where it operates, and how it makes money.

Evolus, Inc. Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 372

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

shop
Company facts
David Moatazedi
CEO
372
Employees worldwide
shop
Performance
-66.46%
Last 12 months
-23.49%
Last 5 years
shop
Growth
$266,27M
Revenue year
$-50.420.000
Net income
shop
Valuation
$320,86M
Market Cap
-13.58
Price/Earnings Ratio

Stocks related to Evolus, Inc.

Selected based on industry alignment and relative market positioning.

LFCR
Lifecore Biomedical, Inc.
8.67
-1.70%
5.3
Sell
Buy
Lifecore Biomedical, Inc.
SNDL
SNDL Inc.
1.60
+0.63%
8.7
Sell
Buy
SNDL Inc.
SIGA
SIGA Technologies, Inc.
6.82
+0.44%
8.3
Sell
Buy
SIGA Technologies, Inc.
OGI.TO
OrganiGram Holdings Inc.
2.23
+1.83%
7.8
Sell
Buy
OrganiGram Holdings Inc.
OGI
Organigram Global Inc.
1.65
+3.13%
7.6
Sell
Buy
Organigram Global Inc.

Evolus, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.